Full coverage· Tech· Updated
AI Designs Active Viruses in Lab, Raising New Ethical and Safety Questions
Researchers used AI to design and create active bacteriophages in the lab, demonstrating potential for treating antibiotic-resistant bacteria but raising safety and ethical concerns about synthetic biology's misuse.
2 newsrooms · 1 language · since
Plus
What happened
- 01AI designed hundreds of bacteriophage genetic codes, with 16 producing active viruses in lab tests.
- 02New phages showed effectiveness against antibiotic-resistant E. coli bacteria.
- 03AI models Evo 1 and Evo 2 learned DNA language to generate genetic sequences.
- 04Experts warn of risks from synthetic biology combined with AI, including potential misuse.
- 05Current technology is early-stage; only a small fraction of AI designs are viable viruses.
- 06AI tools could accelerate vaccine and drug development but require strict oversight.
Experts highlight both the promise and risks of AI-driven biological design, emphasizing the need for careful regulation and further research.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- Centre1
- RightNone
- HarediNone
- ArabNone
- Other1